Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 172,783Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Ryzodeg

02 7Tresiba

03 6Xultophy

PharmaCompass

01

Brand Name : Tresiba

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed

Brand Name : Tresiba

arrow
MAGHREB PHARMA
Not Confirmed

Insulin Degludec

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 1,459

2019 Revenue in Millions : 1,506

Growth (%) : -3

blank

02

Brand Name : Ryzodeg

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed

03

Brand Name : Xultophy

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed

04

Brand Name : Ryzodeg

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed

05

Brand Name : Xultophy

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed

06

Brand Name : Tresiba

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed

Brand Name : Tresiba

arrow
MAGHREB PHARMA
Not Confirmed

Insulin Degludec

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 1,483

2020 Revenue in Millions : 1,435

Growth (%) : 8

blank

07

Brand Name : Ryzodeg

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed

08

Brand Name : Tresiba

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed

Brand Name : Tresiba

arrow
MAGHREB PHARMA
Not Confirmed

Insulin Degludec

Main Therapeutic Indication : Diabetes

Currency : USD

2022 Revenue in Millions : 1,364

2021 Revenue in Millions : 1,483

Growth (%) : -8

blank

09

Brand Name : Xultophy

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed

10

Brand Name : Ryzodeg

Insulin Degludec

arrow
MAGHREB PHARMA
Not Confirmed